10-Q: ATI Physical Therapy Reports Improved Revenue and Reduced Losses in Q2 2024, but Going Concern Doubts Remain

ATI Physical Therapy saw revenue growth and reduced net losses in the second quarter of 2024, but substantial doubt remains about its ability to continue as a going concern.

Summary

• ATI Physical Therapy reported a net loss of $2.6 million for the three months ended June 30, 2024, a significant improvement compared to the $21.7 million loss in the same period of 2023.
• Net patient revenue increased by 10.1% to $172.8 million in Q2 2024, driven by higher patient visit volumes and a higher net revenue per visit.
• The company's total patient visits increased by 6.4% year-over-year, with an average of 24,921 visits per day.
• Net patient revenue per visit rose to $108.32, a 3.4% increase compared to $104.74 in Q2 2023.
• For the six months ended June 30, 2024, the net loss was $16.1 million, compared to $47.0 million for the same period in 2023.
• The company's cash and cash equivalents stood at $33.0 million as of June 30, 2024, with no available capacity under its revolving credit facility.
• ATI is actively seeking additional liquidity in 2024 to meet working capital needs and debt obligations.
• The company's management has expressed substantial doubt about its ability to continue as a going concern due to negative operating cash flows and net losses.

Sentiment

Score: 4

Explanation: While the company shows improvement in revenue and reduced losses, the substantial doubt about its ability to continue as a going concern and the need for additional capital raise a significant concern, resulting in a low sentiment score.

Positives

• ATI experienced a significant reduction in net losses for both the three and six months ended June 30, 2024.
• The company saw a notable increase in net patient revenue, driven by higher visit volumes and revenue per visit.
• ATI's same clinic revenue growth rate showed a strong increase of 10.9% for the three months ended June 30, 2024.
• The company is actively working to improve its operating results and cash flow through various initiatives.
• The company is in compliance with its minimum liquidity covenant under the 2022 Credit Agreement.

Negatives

• ATI continues to generate negative operating cash flows and net losses.
• The company's management has expressed substantial doubt about its ability to continue as a going concern.
• ATI has no available capacity under its revolving credit facility as of June 30, 2024.
• The company is at risk of insufficient funding to meet its obligations and potential non-compliance with its minimum liquidity financial covenant.
• The company is reliant on additional financing to meet its future liquidity needs.

Risks

• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.
• ATI faces risks associated with its ability to generate sufficient cash flows to cover liquidity and capital requirements.
• The company's ability to meet financial covenants under its 2022 Credit Agreement is a concern.
• ATI is dependent on reimbursement by governmental and third-party payors, and changes in reimbursement rates could adversely affect its financial results.
• The company faces competition for experienced physical therapists and other clinical providers, which may increase labor costs.
• The company's operations are subject to extensive regulation and macroeconomic uncertainty.
• The company's inability to maintain effective internal control over financial reporting is a risk.
• The company is subject to risks related to dilution of common stock ownership interests and voting interests as a result of the issuance of 2L Notes and Series B Preferred Stock.

Future Outlook

The company plans to continue its efforts to improve its operating results and cash flow through increases to clinical staffing levels, improvements in clinician productivity, controlling costs and capital expenditures and increases in patient visit volumes, referrals and rate per visit. The company expects to need and is in the process of seeking additional liquidity in 2024.

Management Comments

• Management has expressed substantial doubt about the company's ability to continue as a going concern.
• Management is actively seeking additional liquidity in 2024 to meet working capital needs and debt obligations.
• Management plans have not been fully implemented and, as a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.

Industry Context

The report highlights the ongoing challenges in the physical therapy industry, including a tight labor market, wage inflation, and changes in reimbursement rates. The company's performance is affected by these industry-wide trends, as well as specific factors such as Medicare rate cuts and competition for clinical staff.

Comparison to Industry Standards

• While the document does not provide specific comparisons to industry standards, it does mention that the company is experiencing similar challenges to other healthcare providers in the industry, such as competition for experienced physical therapists and other clinical providers.
• The document notes that the company is working to improve its operating results and cash flow through increases to clinical staffing levels, improvements in clinician productivity, controlling costs and capital expenditures and increases in patient visit volumes, referrals and rate per visit, which are common strategies used by companies in the physical therapy industry.
• The document also mentions that the company is subject to changes in Medicare and Medicaid reimbursement rates, which is a common risk for companies in the healthcare industry.

Management Changes

Legal Proceedings

• The company is involved in various legal proceedings, including stockholder class action complaints, a stockholder derivative complaint, and an insurance coverage complaint.
• The parties to the litigations reached an agreement to resolve all four cases for $26.5 million, which received preliminary approval from the courts.
• The company has recorded an estimated liability of $26.5 million related to the settlements and a corresponding insurance recovery receivable of $26.5 million.

Related Party Transactions

• The company has 2L Notes due to related parties, including Knighthead, Marathon, and Onex.
• The company exchanged a principal amount of $100.0 million of the Senior Secured Term Loan for 2L Notes with related parties as part of the 2023 Debt Restructuring.
• The company issued an additional $25.0 million of 2L Notes to related parties under its Delayed Draw Right.

Stakeholder Impact

• Shareholders face the risk of dilution due to the issuance of 2L Notes and Series B Preferred Stock.
• Employees may be affected by the company's efforts to control costs and improve efficiency.
• Customers may experience changes in service delivery as the company works to improve its operations.
• Creditors face the risk of non-payment if the company is unable to secure additional financing or improve its financial performance.

Next Steps

• The company plans to continue its efforts to improve its operating results and cash flow.
• The company is actively seeking additional liquidity in 2024.
• The company is working to increase clinical staffing levels, improve clinician productivity, control costs, and increase patient visit volumes and referrals.

Key Dates

Keywords

physical therapy, outpatient rehabilitation, net patient revenue, patient visits, EBITDA, debt restructuring, liquidity, going concern, 2L Notes, clinical staffing, healthcare services